SCHEMBL2802761

SCHEMBL2802761

c1ccc2c(c1)Cc1cc(N3CCN4CCC3CC4)ccc1-2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.59
CHRNA1 P02708 4/20 0.50
CHRNB2 P17787 4/20 0.50
CHRNB4 P30926 4/20 0.50
CHRNA3 P32297 4/20 0.50
CHRNA4 P43681 4/20 0.50
CHRNA7 P36544 3/20 0.50
HTR3A P46098 2/20 0.50
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
OPRM1 P35372 1/20 0.39
OPRK1 P41145 1/20 0.39
OPRL1 P41146 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1793080 0.77 KCNH2 (0.62) KCNH2CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL30930843 0.74 KCNH2 (1.00) KCNH2CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL1793916 0.74 KCNH2 (1.00) KCNH2CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL30930842 0.74 KCNH2 (1.00) KCNH2CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL28492509 0.72 NPC1 (0.52) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL5832695 0.70 SLC6A2 (0.46) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL5346985 0.70 KCNH2 (0.50) KCNH2CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL2762809 0.70 CHRNA3 (0.67) CHRNA3CHRNA7HTR3A
SCHEMBL2762690 0.69 CHRNA3 (0.45) CHRNA3CHRNA7HTR3ASLC6A2SLC6A4
SCHEMBL5833414 0.69 SLC6A2 (0.42) CHRNB4CHRNA3KDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2258682-A2 Amino-substituted tricyclic derivatives and methods of use Abbott Laboratories (US) 2010-12-08 EP disclosed